Showing results (511-520 of 661) with videos related to

Sort By:
Pageof 67
Plos One|July 7, 2011
Elevated BCRP/ABCG2 expression confers acquired resistance to gefitinib in wild-type EGFR-expressing cellsYun-Ju Chen, Wei-Chien Huang, Ya-Ling Wei, et al.
Cancer Research|July 5, 2011
Increased VEGFR-2 gene copy is associated with chemoresistance and shorter survival in patients with non-small-cell lung carcinoma who receive adjuvant chemotherapyFei Yang, Ximing Tang, Erick Riquelme, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 29, 2019
Radiation-induced hypoglossal nerve palsy after definitive radiotherapy for nasopharyngeal carcinoma: Clinical predictors and dose-toxicity relationshipJames C H Chow, Ka-Man Cheung, Kwok-Hung Au, et al.
Advances in Therapy|July 9, 2021
Pembrolizumab in Patients with Refractory Cutaneous Squamous Cell Carcinoma: A Phase II TrialRenata Ferrarotto, Luana G Sousa, Yun Qing, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 2009
Induction chemotherapy and cetuximab for locally advanced squamous cell carcinoma of the head and neck: results from a phase II prospective trialMerrill S Kies, Floyd Christopher Holsinger, J Jack Lee, et al.
The Lancet. Oncology|March 20, 2026
A practical toolkit with recommendations for analysing and visualising patient-reported outcomes in early phase dose-finding oncology trials (OPTIMISE-AR)Emily Alger, Antoine Regnault, Amylou C Dueck, et al.
Journal of the National Cancer Institute|April 5, 2017
Next-Generation CDK2/9 Inhibitors and Anaphase Catastrophe in Lung CancerMasanori Kawakami, Lisa Maria Mustachio, Jaime Rodriguez-Canales, et al.
Contemporary Clinical Trials|July 3, 2021
Alternative dosing of exemestane in postmenopausal women with ER-positive breast cancer. Design and methods of a randomized presurgical trialAliana Guerrieri-Gonzaga, Davide Serrano, Parjhitham Thomas, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 3, 2021
Genotype-Specific Differences in Circulating Tumor DNA Levels in Advanced NSCLCVincent K Lam, Jianjun Zhang, Carol C Wu, et al.
Journal for Immunotherapy of Cancer|February 23, 2022
ISA101 and nivolumab for HPV-16+ cancer: updated clinical efficacy and immune correlates of responseLuana Guimaraes de Sousa, Kimal Rajapakshe, Jaime Rodriguez Canales, et al.
Pageof 67